Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10771 | 1036 | 30.8 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
401 | 2 | TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION | 16732 |
10771 | 1 | PLATELET TRANSFUSION//PLATELET REFRACTORINESS//PLATELET TRANSFUSIONS | 1036 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PLATELET TRANSFUSION | authKW | 729065 | 8% | 28% | 88 |
2 | PLATELET REFRACTORINESS | authKW | 537614 | 2% | 79% | 23 |
3 | PLATELET TRANSFUSIONS | authKW | 175445 | 2% | 37% | 16 |
4 | TRANSFUSION | journal | 162189 | 20% | 3% | 205 |
5 | PLATELET TRANSFUSION REFRACTORINESS | authKW | 149198 | 1% | 56% | 9 |
6 | PROPHYLACTIC PLATELET TRANSFUSION | authKW | 147364 | 0% | 100% | 5 |
7 | HLA ALLOIMMUNIZATION | authKW | 122801 | 0% | 83% | 5 |
8 | CORRECTED COUNT INCREMENT | authKW | 110948 | 1% | 47% | 8 |
9 | ALLOIMMUNIZATION | authKW | 103693 | 3% | 11% | 31 |
10 | PLATELET DOSE | authKW | 94311 | 0% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 57542 | 71% | 0% | 737 |
2 | Immunology | 368 | 11% | 0% | 111 |
3 | Medicine, General & Internal | 273 | 9% | 0% | 94 |
4 | Transplantation | 244 | 4% | 0% | 37 |
5 | Medical Laboratory Technology | 209 | 3% | 0% | 27 |
6 | Oncology | 92 | 7% | 0% | 73 |
7 | Pathology | 80 | 3% | 0% | 33 |
8 | Medicine, Research & Experimental | 23 | 3% | 0% | 31 |
9 | BIOLOGY, MISCELLANEOUS | 17 | 0% | 0% | 1 |
10 | Peripheral Vascular Diseases | 3 | 1% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NHSBT MRC CLIN STUDIES UNIT | 58945 | 0% | 100% | 2 |
2 | NHS BLOOD TRANSPLANT | 44564 | 2% | 9% | 17 |
3 | SYSTEMAT REVIEW INITIAT | 39121 | 1% | 15% | 9 |
4 | ADM SECT COORDINATING COMM | 29473 | 0% | 100% | 1 |
5 | AMORY BRIGHAM WOMENS HOSP 260 | 29473 | 0% | 100% | 1 |
6 | AUGUSTO PI SUNYER MEM BIOMED | 29473 | 0% | 100% | 1 |
7 | BIOMED DIAGNOST AGUSTI PI I SUNYER BIOMED | 29473 | 0% | 100% | 1 |
8 | BLOOD BANK HE IS SERV | 29473 | 0% | 100% | 1 |
9 | BLOOD SERV MIDLANDS SW ZONE | 29473 | 0% | 100% | 1 |
10 | BLOOD SERV YORKSHIRE | 29473 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSFUSION | 162189 | 20% | 3% | 205 |
2 | VOX SANGUINIS | 42296 | 7% | 2% | 75 |
3 | TRANSFUSION MEDICINE REVIEWS | 13466 | 2% | 3% | 16 |
4 | BEITRAGE ZUR INFUSIONSTHERAPIE/CONTRIBUTIONS TO INFUSION THERAPY | 12128 | 2% | 2% | 22 |
5 | TRANSFUSION AND APHERESIS SCIENCE | 10812 | 2% | 2% | 23 |
6 | TRANSFUSION CLINIQUE ET BIOLOGIQUE | 8591 | 2% | 2% | 18 |
7 | PLASMA THERAPY & TRANSFUSION TECHNOLOGY | 7239 | 1% | 3% | 8 |
8 | TRANSFUSION SCIENCE | 6404 | 1% | 2% | 11 |
9 | BRITISH JOURNAL OF HAEMATOLOGY | 6322 | 5% | 0% | 54 |
10 | BLOOD | 6271 | 8% | 0% | 86 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ESTCOURT, LJ , STANWORTH, S , DOREE, C , TRIVELLA, M , HOPEWELL, S , BLANCO, P , MURPHY, MF , (2015) DIFFERENT DOSES OF PROPHYLACTIC PLATELET TRANSFUSION FOR PREVENTING BLEEDING IN PEOPLE WITH HAEMATOLOGICAL DISORDERS AFTER MYELOSUPPRESSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - | 94 | 60% | 0 |
2 | ESTCOURT, LJ , STANWORTH, SJ , DOREE, C , HOPEWELL, S , TRIVELLA, M , MURPHY, MF , (2015) COMPARISON OF DIFFERENT PLATELET COUNT THRESHOLDS TO GUIDE ADMINISTRATION OF PROPHYLACTIC PLATELET TRANSFUSION FOR PREVENTING BLEEDING IN PEOPLE WITH HAEMATOLOGICAL DISORDERS AFTER MYELOSUPPRESSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 92 | 57% | 1 |
3 | CRIGHTON, GL , ESTCOURT, LJ , WOOD, EM , TRIVELLA, M , DOREE, C , STANWORTH, S , (2015) A THERAPEUTIC-ONLY VERSUS PROPHYLACTIC PLATELET TRANSFUSION STRATEGY FOR PREVENTING BLEEDING IN PATIENTS WITH HAEMATOLOGICAL DISORDERS AFTER MYELOSUPPRESSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 84 | 60% | 0 |
4 | STANWORTH, SJ , NAVARRETE, C , ESTCOURT, L , MARSH, J , (2015) PLATELET REFRACTORINESS - PRACTICAL APPROACHES AND ONGOING DILEMMAS IN PATIENT MANAGEMENT.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 171. ISSUE 3. P. 297 -305 | 50 | 89% | 4 |
5 | DELAFLOR-WEISS, E , MINTZ, PD , (2000) THE EVALUATION AND MANAGEMENT OF PLATELET REFRACTORINESS AND ALLOIMMUNIZATION.TRANSFUSION MEDICINE REVIEWS. VOL. 14. ISSUE 2. P. 180 -196 | 84 | 79% | 25 |
6 | ESTCOURT, L , STANWORTH, S , DOREE, C , HOPEWELL, S , MURPHY, MF , TINMOUTH, A , HEDDLE, N , (2012) PROPHYLACTIC PLATELET TRANSFUSION FOR PREVENTION OF BLEEDING IN PATIENTS WITH HAEMATOLOGICAL DISORDERS AFTER CHEMOTHERAPY AND STEM CELL TRANSPLANTATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - | 67 | 65% | 9 |
7 | MCFARLAND, JG , (1996) ALLOIMMUNIZATION AND PLATELET TRANSFUSION.SEMINARS IN HEMATOLOGY. VOL. 33. ISSUE 4. P. 315-328 | 86 | 80% | 17 |
8 | HOD, E , SCHWARTZ, J , (2008) PLATELET TRANSFUSION REFRACTORINESS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 142. ISSUE 3. P. 348 -360 | 62 | 62% | 73 |
9 | VASSALLO, RR , FUNG, M , REBULLA, P , DUQUESNOY, R , SAW, CL , SLICHTER, SJ , TANAEL, S , SHEHATA, N , (2014) UTILITY OF CROSS-MATCHED PLATELET TRANSFUSIONS IN PATIENTS WITH HYPOPROLIFERATIVE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW.TRANSFUSION. VOL. 54. ISSUE 4. P. 1180-1191 | 37 | 97% | 6 |
10 | NAHIRNIAK, S , SLICHTER, SJ , TANAEL, S , REBULLA, P , PAVENSKI, K , VASSALLO, R , FUNG, M , DUQUESNOY, R , SAW, CL , STANWORTH, S , ET AL (2015) GUIDANCE ON PLATELET TRANSFUSION FOR PATIENTS WITH HYPOPROLIFERATIVE THROMBOCYTOPENIA.TRANSFUSION MEDICINE REVIEWS. VOL. 29. ISSUE 1. P. 3 -13 | 43 | 68% | 13 |
Classes with closest relation at Level 1 |